Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: paclitaxel|DRUG: Fluorouracil|DRUG: Epirubicin|DRUG: Cyclophosphamide
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Bristol-Myers Squibb|Pfizer|Hoffmann-La Roche